Berman Capital Advisors’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Berman Capital Advisors’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1K	Buy	+71	New	+$1.43K	﹤0.01%	2032

Other funds holding OCDX

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Berman Capital Advisors's OCDX Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q3 2021: 71 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2032 among its holdings.

140 funds tracked by Wall St. Rank hold OCDX as of Q3 2021.

Berman Capital Advisors held 71 shares of Ortho Clinical Diagnostics Holdings plc Ordinary Shares worth $1K as of Q3 2021.
Ortho Clinical Diagnostics Holdings plc Ordinary Shares was a new Berman Capital Advisors position in Q3 2021.
Ortho Clinical Diagnostics Holdings plc Ordinary Shares made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #2032 holding.
140 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.